http://www.amgennews.com/index.php en pmannle@amgen.com Copyright 2010 2010-07-29T21:02:01+00:00 http://www.amgennews.com/index.php/2008NewsService/amgens_second_quarter_2010_adjusted_earnings_per_share_increased_7_percent_/ http://www.amgennews.com/index.php/2008NewsService/amgens_second_quarter_2010_adjusted_earnings_per_share_increased_7_percent_/#When:21:02:01Z Second Quarter 2010 Revenue Increased 2 Percent to $3.8 Billion Second Quarter 2010 GAAP Earnings Per Share Unchanged at $1.25 Adjusting for the Impact of a Weaker Euro, 2010 Total Revenue Guidance Revised to Slightly Below $15.1 Billion 2010 Adjusted Earnings Per Share Guidance Unchanged at Towards Lower End of $5.05-$5.25 THOUSAND OAKS, Calif., July 29, 2010 /PRNewswire via COMTEX/—Amgen (Nasdaq: AMGN) reported adjusted earnings per share (EPS) of $1.38 for the second quarter of 2010, an increase of 7 percent compared to $1.29 for the second quarter of 2009. Adjusted net income increased 1 percent to $1,326 million for the second quarter of 2010 compared to $1,311 million for the second quarter of 2009. Press Releases 2010-07-29T21:02:01+00:00 http://www.amgennews.com/index.php/2008NewsService/2010_addressing_psoriasis_contest_winners_attend_a_style_consultation_with_/ http://www.amgennews.com/index.php/2008NewsService/2010_addressing_psoriasis_contest_winners_attend_a_style_consultation_with_/#When:19:25:00Z Five Winners with Moderate to Severe Plaque Psoriasis Receive Individualized Advice to Help Achieve Their Best Personal Style NEW YORK, July 28, 2010 /PRNewswire via COMTEX/—Amgen and Pfizer today announced the five winners of the 2010 Addressing Psoriasis™ contest, which recognizes people with moderate to severe plaque psoriasis who want to feel more confident in their everyday style.  The winners have traveled to New York City where they will receive a one-on-one consultation with Tim Gunn, mentor to the designers on TV’s "Project Runway" and chief creative officer of Liz Claiborne, Inc. Gunn will help the winners embrace their personal style and work with them to select outfits that complement their individual looks and lifestyles, and that work with their psoriasis. The winners’ stories and experiences will help raise public awareness of psoriasis. The 2010 contest winners are: Press Releases 2010-07-28T19:25:00+00:00 http://www.amgennews.com/index.php/2008NewsService/amgen_announces_webcast_of_2010_second_quarter_financial_results/ http://www.amgennews.com/index.php/2008NewsService/amgen_announces_webcast_of_2010_second_quarter_financial_results/#When:18:54:01Z THOUSAND OAKS, Calif., July 26, 2010 /PRNewswire via COMTEX/—Amgen (Nasdaq: AMGN) today announced that it plans to report its second quarter financial results on Thursday, July 29, 2010 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. Pacific Time. Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen’s senior management team. Press Releases 2010-07-26T18:54:01+00:00 http://www.amgennews.com/index.php/2008NewsService/amgen_appoints_ronald_d_sugar_to_the_companys_board_of_directors/ http://www.amgennews.com/index.php/2008NewsService/amgen_appoints_ronald_d_sugar_to_the_companys_board_of_directors/#When:23:55:00Z THOUSAND OAKS, Calif., July 22, 2010 /PRNewswire via COMTEX/—Amgen (Nasdaq: AMGN) today announced that its board of directors has appointed Ronald D. Sugar to the company’s board, effective immediately.  Dr. Sugar, 61, is chairman emeritus of Northrop Grumman Corp. and served as the company’s chairman and chief executive officer from 2003 to 2009. He was president and chief operating officer of Northrop from 2001 to 2003. He has been a director of Chevron Corporation since 2005. Press Releases 2010-07-22T23:55:00+00:00 http://www.amgennews.com/index.php/2008NewsService/amgen_scholars_summer_research_helps_lead_to_science_careers/ http://www.amgennews.com/index.php/2008NewsService/amgen_scholars_summer_research_helps_lead_to_science_careers/#When:17:07:00Z THOUSAND OAKS, Calif. (July 19, 2010) – A Rhodes Scholar, a Labouisse winner, a Hertz Foundation Fellow and co-author of an internationally acclaimed research project – these are just a few examples of what alumni of the Amgen Scholars Program  have achieved. Press Releases 2010-07-19T17:07:00+00:00 http://www.amgennews.com/index.php/2008NewsService/fda_grants_priority_review_designation_to_denosumab_biologics_license_appli/ http://www.amgennews.com/index.php/2008NewsService/fda_grants_priority_review_designation_to_denosumab_biologics_license_appli/#When:22:47:00Z FDA Accepts Submission Which Includes Data from Three Pivotal Phase 3 Trials THOUSAND OAKS, Calif., July 16, 2010 /PRNewswire via COMTEX/—Amgen (Nasdaq: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer. Filed in mid-May with the FDA, the Biologics License Application (BLA) submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three pivotal Phase 3 head-to-head trials versus Zometa(R) (zoledronic acid). Press Releases 2010-07-16T22:47:00+00:00 http://www.amgennews.com/index.php/2008NewsService/amgen_appoints_jonathan_m_peacock_executive_vice_president_and_chief_financ/ http://www.amgennews.com/index.php/2008NewsService/amgen_appoints_jonathan_m_peacock_executive_vice_president_and_chief_financ/#When:20:05:00Z THOUSAND OAKS, Calif., July 15, 2010 /PRNewswire via COMTEX/—Amgen (Nasdaq: AMGN) today announced the appointment effective Sept. 1 of Jonathan M. Peacock as chief financial officer (CFO). He will be responsible for Amgen’s finance and investor relations operations. Peacock will report to Kevin W. Sharer, Amgen’s chairman and chief executive officer, and will succeed Michael A. Kelly, who served as acting CFO since May 2010. Press Releases 2010-07-15T20:05:00+00:00 http://www.amgennews.com/index.php/2008NewsService/amgen_foundation_and_changemakers_launch_global_online_competition_to_empow/ http://www.amgennews.com/index.php/2008NewsService/amgen_foundation_and_changemakers_launch_global_online_competition_to_empow/#When:19:36:01Z THOUSAND OAKS, Calif. and WASHINGTON, July 14, 2010 /PRNewswire via COMTEX/ — The Amgen Foundation is supporting an online competition with Ashoka’s Changemakers to find the best solutions that elevate patients’ voices to improve health outcomes globally. Press Releases 2010-07-14T19:36:01+00:00 http://www.amgennews.com/index.php/2008NewsService/34_teachers_and_schools_across_north_america_receive_10000_amgen_award_for_/ http://www.amgennews.com/index.php/2008NewsService/34_teachers_and_schools_across_north_america_receive_10000_amgen_award_for_/#When:23:33:01Z THOUSAND OAKS, Calif., June 22, 2010 /PRNewswire via COMTEX/ --Amgen (Nasdaq: AMGN) today announced the 34 science teachers in the United States (U.S.), Canada and Puerto Rico who are this year’s recipients of the 18th annual Amgen Award for Science Teaching Excellence. The award recognizes extraordinary teachers in grades K-12 whose dedication to students has had a significant impact on the learning and interest of the future generation of scientists. Press Releases 2010-06-22T23:33:01+00:00 http://www.amgennews.com/index.php/2008NewsService/amgen_to_present_at_the_goldman_sachs_global_healthcare_conference/ http://www.amgennews.com/index.php/2008NewsService/amgen_to_present_at_the_goldman_sachs_global_healthcare_conference/#When:21:07:00Z THOUSAND OAKS, Calif., June 15, 2010 /PRNewswire via COMTEX/ --Amgen (Nasdaq: AMGN) will present at the Goldman Sachs Global Healthcare Conference on Thursday, June 17, 2010 at the Century Plaza Hyatt Regency, Los Angeles, beginning at 9:20 a.m. Pacific Time. Amgen Chairman and CEO Kevin Sharer will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s website, www.amgen.com, under Investors. Press Releases 2010-06-15T21:07:00+00:00